Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Net Cash Flow (2016 - 2025)

Nu-Med Plus' Net Cash Flow history spans 10 years, with the latest figure at -$20165.0 for Q4 2021.

  • On a quarterly basis, Net Cash Flow fell 112.84% to -$20165.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$176831.0, a 197.47% decrease, with the full-year FY2025 number at -$1712.0, up 61.38% from a year prior.
  • Net Cash Flow hit -$20165.0 in Q4 2021 for Nu-Med Plus, up from -$40991.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for NUMD hit a ceiling of $305097.0 in Q1 2017 and a floor of -$144237.0 in Q1 2019.
  • Historically, Net Cash Flow has averaged -$38.75 across 5 years, with a median of -$16193.5 in 2020.
  • Biggest five-year swings in Net Cash Flow: tumbled 4540.72% in 2019 and later skyrocketed 551.7% in 2020.
  • Tracing NUMD's Net Cash Flow over 5 years: stood at -$58270.0 in 2017, then surged by 98.71% to -$749.0 in 2018, then tumbled by 4540.72% to -$34759.0 in 2019, then skyrocketed by 551.7% to $157008.0 in 2020, then plummeted by 112.84% to -$20165.0 in 2021.
  • Business Quant data shows Net Cash Flow for NUMD at -$20165.0 in Q4 2021, -$40991.0 in Q3 2021, and -$66434.0 in Q2 2021.